INCY vs ISRG: fair value comparison
Incyte Corporation and Intuitive Surgical, Inc. · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, ISRG currently sits closer to the top of our ranking by discount to fair value.
| INCY | ISRG | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $112.79 | $423.96 |
| 12-month range | $90.18–$129.93 | $332.02–$592.85 |
| Rank by discount to fair value | #23 of 108 Healthcare | #20 of 108 Healthcare |
| Quality grade | A | A |
| Momentum grade | — | A |
| Leverage | Low | — |
| Margin trend | Stable | Stable |
| Revenue growth | High | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | — |
| 52-week position | The upper-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: INCY fair value analysis · ISRG fair value analysis